RDY Retained Earnings from 2010 to 2025

RDY Stock

USD 13.60 0.39 2.79%

Dr Reddys Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings are likely to outpace its year average in 2025. Retained Earnings is the cumulative amount of net income that Dr Reddys Laboratories retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2000-03-31

Previous Quarter

285.2 B

Current Value

299.4 B

Quarterly Volatility

79 B

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 2.1 B, Total Revenue of 337.1 B or Gross Profit of 197.6 B, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0271 or PTB Ratio of 0.86. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.

Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Dr Reddys Laboratories over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Dr Reddys' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 265.26 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

RDY Retained Earnings Regression Statistics

	Arithmetic Mean	141,221,051,906
	Geometric Mean	77,110,856,754
	Coefficient Of Variation	67.27
	Mean Deviation	74,442,376,770
	Median	128,646,000,000
	Standard Deviation	95,004,675,132
	Sample Variance	9025888296.8T
	Range	320.2B
	R-Value	0.97
	Mean Square Error	522933563.7T
	R-Squared	0.95
	Slope	19,407,946,717
	Total Sum of Squares	135388324452.7T

RDY Retained Earnings History

	2025	320.3 B
	2024	305 B
	2023	265.3 B
	2022	215.6 B
	2021	175.7 B
	2020	157.9 B
	2019	144.2 B

Other Fundumenentals of Dr Reddys Laboratories

Retained Earnings Total Equity

Dr Reddys Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Net Receivables	Good Will	Total Current Assets	Treasury Stock	Short Term Debt	Net Tangible Assets	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.1	0.97	-0.15	0.93	0.97	0.89	0.95	-0.06	-0.04	0.93	0.98	0.98	1.0	-0.06	0.93	0.07	-0.04	0.13	-0.18	-0.16	0.17	0.14	0.12	0.16
Total Stockholder Equity	0.98		0.29	0.91	-0.16	0.97	0.89	0.86	0.87	0.1	0.07	0.84	0.93	0.91	0.99	-0.23	0.83	0.22	0.08	0.01	-0.21	-0.1	0.19	0.31	0.29	0.3
Retained Earnings	0.1	0.29		-0.11	0.05	0.35	-0.15	0.07	-0.2	0.84	0.58	-0.24	-0.04	-0.11	0.13	-0.83	-0.26	0.69	0.63	-0.55	-0.06	0.33	0.04	0.83	0.85	0.7
Accounts Payable	0.97	0.91	-0.11		-0.13	0.85	1.0	0.9	0.99	-0.22	-0.15	0.97	0.99	0.99	0.96	0.11	0.97	-0.03	-0.15	0.24	-0.14	-0.22	0.15	0.0	-0.02	0.0
Long Term Debt	-0.15	-0.16	0.05	-0.13		-0.24	-0.13	0.18	-0.16	0.38	0.07	-0.06	-0.18	-0.15	-0.19	0.12	-0.16	-0.01	0.19	-0.21	0.99	0.44	-0.49	-0.13	-0.13	-0.07
Short Term Investments	0.93	0.97	0.35	0.85	-0.24		0.83	0.74	0.81	0.07	-0.01	0.76	0.88	0.85	0.95	-0.22	0.76	0.2	-0.03	-0.08	-0.3	-0.12	0.37	0.39	0.37	0.38
Total Liab	0.97	0.89	-0.15	1.0	-0.13	0.83		0.89	1.0	-0.25	-0.16	0.98	0.99	0.99	0.95	0.15	0.99	-0.08	-0.16	0.26	-0.14	-0.23	0.12	-0.07	-0.09	-0.04
Intangible Assets	0.89	0.86	0.07	0.9	0.18	0.74	0.89		0.85	0.11	0.04	0.88	0.89	0.88	0.86	-0.01	0.85	0.11	0.16	0.14	0.17	-0.02	-0.07	0.07	0.07	0.04
Common Stock	0.95	0.87	-0.2	0.99	-0.16	0.81	1.0	0.85		-0.31	-0.21	0.98	0.97	0.99	0.94	0.2	0.99	-0.14	-0.23	0.29	-0.16	-0.26	0.14	-0.13	-0.15	-0.06
Property Plant Equipment	-0.06	0.1	0.84	-0.22	0.38	0.07	-0.25	0.11	-0.31		0.64	-0.3	-0.17	-0.22	-0.06	-0.71	-0.33	0.71	0.76	-0.51	0.33	0.67	-0.24	0.59	0.62	0.45
Current Deferred Revenue	-0.04	0.07	0.58	-0.15	0.07	-0.01	-0.16	0.04	-0.21	0.64		-0.22	-0.06	-0.13	-0.03	-0.81	-0.23	0.62	0.74	-0.42	0.08	0.34	-0.58	0.38	0.46	0.07
Net Debt	0.93	0.84	-0.24	0.97	-0.06	0.76	0.98	0.88	0.98	-0.3	-0.22		0.94	0.97	0.91	0.23	0.98	-0.17	-0.19	0.37	-0.06	-0.3	0.07	-0.18	-0.19	-0.09
Net Receivables	0.98	0.93	-0.04	0.99	-0.18	0.88	0.99	0.89	0.97	-0.17	-0.06	0.94		0.98	0.97	0.03	0.95	0.04	-0.1	0.17	-0.19	-0.19	0.14	0.07	0.06	0.03
Good Will	0.98	0.91	-0.11	0.99	-0.15	0.85	0.99	0.88	0.99	-0.22	-0.13	0.97	0.98		0.96	0.11	0.98	-0.07	-0.15	0.24	-0.15	-0.21	0.13	-0.06	-0.08	-0.01
Total Current Assets	1.0	0.99	0.13	0.96	-0.19	0.95	0.95	0.86	0.94	-0.06	-0.03	0.91	0.97	0.96		-0.09	0.91	0.1	-0.04	0.11	-0.23	-0.18	0.2	0.18	0.16	0.19
Treasury Stock	-0.06	-0.23	-0.83	0.11	0.12	-0.22	0.15	-0.01	0.2	-0.71	-0.81	0.23	0.03	0.11	-0.09		0.26	-0.84	-0.76	0.39	0.18	-0.25	0.19	-0.76	-0.81	-0.42
Short Term Debt	0.93	0.83	-0.26	0.97	-0.16	0.76	0.99	0.85	0.99	-0.33	-0.23	0.98	0.95	0.98	0.91	0.26		-0.21	-0.22	0.34	-0.15	-0.26	0.13	-0.2	-0.23	-0.11
Net Tangible Assets	0.07	0.22	0.69	-0.03	-0.01	0.2	-0.08	0.11	-0.14	0.71	0.62	-0.17	0.04	-0.07	0.1	-0.84	-0.21		0.68	-0.22	-0.07	0.41	-0.16	0.76	0.8	0.41
Long Term Investments	-0.04	0.08	0.63	-0.15	0.19	-0.03	-0.16	0.16	-0.23	0.76	0.74	-0.19	-0.1	-0.15	-0.04	-0.76	-0.22	0.68		-0.08	0.16	0.27	-0.36	0.51	0.53	0.25
Short Long Term Debt	0.13	0.01	-0.55	0.24	-0.21	-0.08	0.26	0.14	0.29	-0.51	-0.42	0.37	0.17	0.24	0.11	0.39	0.34	-0.22	-0.08		-0.18	-0.56	0.03	-0.39	-0.43	-0.27
Long Term Debt Total	-0.18	-0.21	-0.06	-0.14	0.99	-0.3	-0.14	0.17	-0.16	0.33	0.08	-0.06	-0.19	-0.15	-0.23	0.18	-0.15	-0.07	0.16	-0.18		0.45	-0.53	-0.25	-0.24	-0.2
Capital Surpluse	-0.16	-0.1	0.33	-0.22	0.44	-0.12	-0.23	-0.02	-0.26	0.67	0.34	-0.3	-0.19	-0.21	-0.18	-0.25	-0.26	0.41	0.27	-0.56	0.45		-0.26	0.1	0.13	0.03
Cash And Equivalents	0.17	0.19	0.04	0.15	-0.49	0.37	0.12	-0.07	0.14	-0.24	-0.58	0.07	0.14	0.13	0.2	0.19	0.13	-0.16	-0.36	0.03	-0.53	-0.26		0.26	0.2	0.26
Net Invested Capital	0.14	0.31	0.83	0.0	-0.13	0.39	-0.07	0.07	-0.13	0.59	0.38	-0.18	0.07	-0.06	0.18	-0.76	-0.2	0.76	0.51	-0.39	-0.25	0.1	0.26		0.98	0.72
Net Working Capital	0.12	0.29	0.85	-0.02	-0.13	0.37	-0.09	0.07	-0.15	0.62	0.46	-0.19	0.06	-0.08	0.16	-0.81	-0.23	0.8	0.53	-0.43	-0.24	0.13	0.2	0.98		0.65
Capital Stock	0.16	0.3	0.7	0.0	-0.07	0.38	-0.04	0.04	-0.06	0.45	0.07	-0.09	0.03	-0.01	0.19	-0.42	-0.11	0.41	0.25	-0.27	-0.2	0.03	0.26	0.72	0.65

Click cells to compare fundamentals

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Retained Earnings	305 B	320.3 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC